Evidence map›Paper›PMID 31317524›Full record

ArticleEndocrine2019

Prevalence and risk factors for hypoparathyroidism following total thyroidectomy in Spain: a multicentric and nation-wide retrospective analysis.

Juan J Díez, Emma Anda, Julia Sastre, Begoña Pérez Corral, Cristina Álvarez-Escolá, Laura Manjón, Miguel Paja, Marcel Sambo, Piedad Santiago Fernández, Concepción Blanco Carrera and 16 more

Erratum issuedAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Endocrine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 47 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 3 pooled it
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 3 syntheses or guidelines pooled it, 83 citations in OpenAlex.

  1. Pooled it
  2. Etiology and Pathophysiology of Hypoparathyroidism: A Narrative Review.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2022
    Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Clinical manifestations of injured tracheal and esophageal branches of the recurrent laryngeal nerve following thyroid surgery.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Development and Validation of a Prognostic Model for Persistent Hypoparathyroidism After Total or Completion Thyroidectomy.Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery · 2026
    Article
  13. Article
  14. Review
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Hypoparathyroidism: Similarities and differences between Western and Eastern countries.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 19 institutions in 1 country.

Juan J DíezDepartment of Endocrinology, Hospital Universitario Ramón y Cajal, Madrid, Spain. juanjose.diez@salud.madrid.org.ORCID 0000-0002-2017-0694
Emma AndaDepartment of Endocrinology, Complejo Hospitalario de Navarra, Pamplona, Spain.
Julia SastreDepartment of Endocrinology, Complejo Hospitalario de Toledo, Toledo, Spain.
Begoña Pérez CorralDepartment of Endocrinology, Complejo Asistencial Universitario de León, León, Spain.
Cristina Álvarez-EscoláDepartment of Endocrinology, Hospital Universitario La Paz, Madrid, Spain.
Laura ManjónDepartment of Endocrinology, Hospital Universitario Central de Asturias, Oviedo, Spain.
Miguel PajaDepartment of Endocrinology, Hospital Universitario de Basurto, Bilbao, Spain.
Marcel SamboDepartment of Endocrinology, Hospital Universitario Gregorio Marañón, Madrid, Spain.
Piedad Santiago FernándezDepartment of Endocrinology, Complejo Hospitalario de Jaén, Jaén, Spain.
Concepción Blanco CarreraDepartment of Endocrinology, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.
Juan C GalofréDepartment of Endocrinology, Clínica Universidad de Navarra, Pamplona, Spain.
Elena NavarroDepartment of Endocrinology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
Carles ZafónDepartment of Endocrinology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Eva SanzDepartment of Endocrinology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Amelia OleagaDepartment of Endocrinology, Hospital Universitario de Basurto, Bilbao, Spain.
Orosia BandrésDepartment of Endocrinology, Hospital Royo Villanova, Zaragoza, Spain.
Sergio DonnayDepartment of Endocrinology, Fundación Hospital de Alcorcón, Alcorcón, Madrid, Spain.
Ana MegíaDepartment of Endocrinology, Hospital Universitario de Tarragona Joan XXIII, IISPV, Universitat Rovira i Virgili, Ciberdem, Tarragona, Spain.
María PicalloDepartment of Endocrinology, Hospital Universitario Gregorio Marañón, Madrid, Spain.
Cecilia Sánchez RagnarssonDepartment of Endocrinology, Hospital Universitario Central de Asturias, Oviedo, Spain.
Gloria Baena-NietoDepartment of Endocrinology, Hospital de Jerez, Jerez de la Frontera, Cádiz, Spain.
José Carlos Fernández GarcíaDepartment of Endocrinology, Hospital Virgen de la Victoria, Málaga, Spain.
Beatriz LecumberriDepartment of Endocrinology, Hospital Universitario La Paz, Madrid, Spain.
Manel Sahún de la VegaDepartment of Endocrinology, Hospital Moisès Broggi, Sant Joan Despí, Barcelona, Spain.
Ana R Romero-LluchDepartment of Endocrinology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
Pedro IglesiasDepartment of Endocrinology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Hospital de Basurto · ESHospital General Universitario Gregorio Marañón · ESHospital Universitario Central de Asturias · ESHospital Universitario La Paz · ESHospital Universitario Puerta de Hierro Majadahonda · ESHospital Universitario Virgen del Rocío · ESVall d'Hebron Hospital Universitari · ESClinica Universidad de Navarra · ESComplejo Asistencial Universitario de Palencia · ESComplejo Hospitalario de Jaén · ESComplejo Hospitalario de Navarra · ESComplejo Hospitalario Universitario de Toledo · ESHospital Clínico Universitario Virgen de la Victoria · ESHospital de Sant Joan Despí Moisès Broggi · ESHospital Jerez Puerta del Sur · ESHospital Royo Villanova · ESHospital Universitario Fundación Alcorcón · ESHospital Universitario Príncipe de Asturias · ESInstitut de Recerca Biomèdica Catalunya Sud · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe prevalence of postoperative hypoparathyroidism has been studied in registries and in surgical series with highly variable and imprecise results. However, the frequency of this hormonal deficiency in the clinical practice of endocrinologists is not known with accuracy. We aimed to assess the prevalence and risk factors of hypoparathyroidism in patients undergoing total thyroidectomy in Spain.

methodsWe designed a retrospective, multicentre and nation-wide protocol including all patients with total thyroidectomy who were seen in the endocrinology clinic of the participant centers from January to March 2018. Prevalence of hypoparathyroidism was evaluated at discharge of surgery, 3-6 months after surgery, 12 months after surgery and at last visit. Twenty hospitals participated in the study.

resultsOf 1792 patients undergoing total thyroidectomy, 866 (48.3%) developed postoperative hypoparathyroidism at discharge of surgery. Most of them recover parathyroid function over time. Prevalence of hypoparathyroidism at 3-6 months, 12 months and at last visit was 22.9%, 16.7% and 14.5%, respectively. The risk of developing definitive hypoparathyroidism was related to the presence of parathyroid tissue at histology, lymph node dissection, and two-stage thyroidectomy. Patients with thyroid cancer, with higher postoperative calcium levels and treated by expert surgical teams exhibited lower risk of developing permanent hypoparathyroidism.

conclusionsAlthough most patients with postsurgical hypoparathyroidism recover parathyroid function, the prevalence of permanent disease in clinical practice is non negligible (14.5%). Postoperative calcium, extent and timing of surgery, the presence of cancer, expert surgical team, and parathyroid tissue at histology are predictors of permanent hypoparathyroidism.

Indexed as

AdolescentAdultAgedAged, 80 and overFemaleFollow-Up StudiesHumansHypoparathyroidismMaleMiddle AgedPostoperative ComplicationsPrevalenceRetrospective StudiesRisk FactorsSpainThyroidectomyHypocalcemiaHypoparathyroidismPrevalenceRisk factorsThyroidectomyThyroid surgery

Identifiers

PMID31317524
OpenAlexW2959457880

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.